Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination therapy using a dual PPAR-α/PPAR-γ activator and a GLP-1 derivative for the treatment of metabolic syndrome and related diseases and disorders

Combination therapy using a dual PPAR-α/PPAR-γ activator and a GLP-1 derivative for the treatment of metabolic syndrome and related diseases and disorders

US Patent 7202213 · Granted Apr 10, 2007

Estimated economic value: $7,297,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Oral dosing of GLP-1 compounds2025
Closure mechanism2025
Glucose-sensitive albumin-binding derivatives2025
Implantable medical device and assembly2024
Glucose-sensitive albumin-binding derivatives2023
Graft for treating the distal aortic arch and descending aorta in type a patient2023
GLP-1 derivatives and uses thereof2023
Glucose sensitive insulins and uses thereof2023
Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists2022
Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists2022
Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists2022
Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzo2022